Integra Lifesciences Holdings Corp (IART)
23.35
+0.35
(+1.52%)
USD |
NASDAQ |
Nov 22, 10:47
Integra Lifesciences Holdings Total Assets (Quarterly): 4.066B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 4.066B |
June 30, 2024 | 4.074B |
March 31, 2024 | 4.078B |
December 31, 2023 | 3.782B |
September 30, 2023 | 3.739B |
June 30, 2023 | 3.778B |
March 31, 2023 | 3.742B |
December 31, 2022 | 3.890B |
September 30, 2022 | 3.807B |
June 30, 2022 | 3.753B |
March 31, 2022 | 3.672B |
December 31, 2021 | 3.782B |
September 30, 2021 | 3.774B |
June 30, 2021 | 3.713B |
March 31, 2021 | 3.742B |
December 31, 2020 | 3.615B |
September 30, 2020 | 3.454B |
June 30, 2020 | 3.392B |
March 31, 2020 | 3.448B |
December 31, 2019 | 3.303B |
September 30, 2019 | 3.347B |
June 30, 2019 | 3.290B |
March 31, 2019 | 3.206B |
December 31, 2018 | 3.108B |
September 30, 2018 | 3.179B |
Date | Value |
---|---|
June 30, 2018 | 3.186B |
March 31, 2018 | 3.248B |
December 31, 2017 | 3.211B |
September 30, 2017 | 2.418B |
June 30, 2017 | 2.101B |
March 31, 2017 | 2.049B |
December 31, 2016 | 1.808B |
September 30, 2016 | 1.827B |
June 30, 2016 | 1.814B |
March 31, 2016 | 1.830B |
December 31, 2015 | 1.774B |
September 30, 2015 | 1.828B |
June 30, 2015 | 1.638B |
March 31, 2015 | 1.551B |
December 31, 2014 | 1.587B |
September 30, 2014 | 1.546B |
June 30, 2014 | 1.563B |
March 31, 2014 | 1.556B |
December 31, 2013 | 1.192B |
September 30, 2013 | 1.184B |
June 30, 2013 | 1.188B |
March 31, 2013 | 1.156B |
December 31, 2012 | 1.164B |
September 30, 2012 | 1.186B |
June 30, 2012 | 1.162B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
3.303B
Minimum
Dec 2019
4.078B
Maximum
Mar 2024
3.730B
Average
3.748B
Median
Total Assets (Quarterly) Benchmarks
Boston Scientific Corp | 38.08B |
Haemonetics Corp | 2.525B |
ResMed Inc | 7.222B |
Globus Medical Inc | 5.086B |
Perspective Therapeutics Inc | 391.15M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 2.544B |
Shareholders Equity (Quarterly) | 1.522B |
Debt to Equity Ratio | 1.187 |
Current Ratio | 1.205 |
Net Debt Paydown Yield | -5.39% |